Bicycle Therapeutics PLC (BCYC) stock
BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)
Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%
Bicycle Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Bicycle Therapeutics's market cap was $257.61M on Nov 11, 2026, against $518.41M a year earlier. Over the last 5 years it ranged from $255.52M to $1.62B, with a median of $690.04M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $257.61M | -47.5% |
| 2025 | Dec 31, 2025 | $490.69M | -49.2% |
| 2024 | Dec 31, 2024 | $966.22M | +26.1% |
| 2023 | Dec 29, 2023 | $766.32M | -12.8% |
| 2022 | Dec 30, 2022 | $878.48M | -43.6% |
| 2021 | Dec 31, 2021 | $1.56B | +314.6% |
| 2020 | Dec 31, 2020 | $375.80M | +122.6% |
| 2019 | Dec 31, 2019 | $168.82M | – |
See a number that looks wrong?